bw a868c has been researched along with gamma-aminobutyric acid in 1 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Studies (bw a868c) | Trials (bw a868c) | Recent Studies (post-2010) (bw a868c) | Studies (gamma-aminobutyric acid) | Trials (gamma-aminobutyric acid) | Recent Studies (post-2010) (gamma-aminobutyric acid) |
|---|---|---|---|---|---|
| 47 | 0 | 11 | 40,215 | 1,423 | 9,631 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayaishi, O; Ito, S; Minami, T; Mori, H; Okuda-Ashitaka, E | 1 |
1 other study(ies) available for bw a868c and gamma-aminobutyric acid
| Article | Year |
|---|---|
Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice.
Topics: Adrenergic Agonists; Animals; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glycine; Hydantoins; Male; Mice; N-Methylaspartate; Pain; Prostaglandin D2; Spinal Cord; Wakefulness | 1996 |